The effects of cross-linked hemoglobin on regional vascular conductance in dogs

Niki M. Dietz, Crestin M. Martin, A. G. Beltran-del-Rio, Michael Joseph Joyner

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hemoglobin (Hgb) solutions cause systemic vasoconstriction, which might limit their use as intraoperative blood substitutes. This constriction is thought to be caused by interaction between Hgb and nitric oxide (NO). To determine whether α-α cross-linked hemoglobin (XL-Hgb) interferes with NO- mediated vasodilation caused by acetylcholine (ACh) and sodium nitroprusside (NTP), we infused these compounds into the femoral, superior mesenteric, and circumflex coronary arteries of anesthetized dogs (n = 6) before and after partial exchange transfusion with XL-Hgb. Additional animals (n = 6) were studied after treatment with 5% albumin. XL-Hgb administration increased mean arterial pressure (MAP) from 81 ± 5 to 112 ± 8 (P < 0.05). Albumin reduced MAP from 84 ± 4 mm Hg to 76 ± 4 mm Hg (P < 0.05). Vascular conductance after XL-Hgb decreased in the femoral artery, was not changed in the mesenteric bed, and increased modestly in the coronary artery (from 0.19 ± 0.03 to 0.26 ± 0.02 mL · mm Hg -1 · min -1, P < 0.05). After albumin, conductance was unchanged in the femoral artery and increased in the mesenteric artery. Conductance also increased in the coronary bed (from 0.25 ± 0.02 to 0.49 ± 0.03 mL · mm Hg -1 · min -1, P < 0.05). The vasodilator response to ACh in the femoral or mesenteric beds was either unaffected or augmented by either XL-Hgb or albumin. In the coronary bed, XL- Hgb blunted the dilator responses to ACh and NTP, while albumin augmented the coronary dilator responses to ACh. In five additional dogs, the NO synthase inhibitor N(G)-monomethyl L-arginine caused MAP to increase from 85 ± 4 to 90 ± 8 mm Hg and blunted the coronary dilator responses to ACh by approximately 25%. Subsequent XL-Hgb administration caused a further increase in MAP to 112 ± 19 mm Hg (P < 0.05) and also further blunted ACh-mediated vasodilator responses in the coronary circulation. XL-Hgb has complex effects on the circulatory system, including a reduction in the vasodilator responses to ACh and NTP in canine coronary arteries in vivo. The potential impact of these events on patients with significant coexisting disease is unclear.

Original languageEnglish (US)
Pages (from-to)265-273
Number of pages9
JournalAnesthesia and Analgesia
Volume85
Issue number2
DOIs
StatePublished - Aug 1997

Fingerprint

Blood Vessels
Hemoglobins
Dogs
Acetylcholine
Albumins
Arterial Pressure
Nitroprusside
Vasodilator Agents
Coronary Vessels
Femoral Artery
Thigh
Blood Substitutes
Coronary Circulation
Mesenteric Arteries
Cardiovascular System
Vasoconstriction
Constriction
Vasodilation
Nitric Oxide Synthase
Arginine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The effects of cross-linked hemoglobin on regional vascular conductance in dogs. / Dietz, Niki M.; Martin, Crestin M.; Beltran-del-Rio, A. G.; Joyner, Michael Joseph.

In: Anesthesia and Analgesia, Vol. 85, No. 2, 08.1997, p. 265-273.

Research output: Contribution to journalArticle

Dietz, Niki M. ; Martin, Crestin M. ; Beltran-del-Rio, A. G. ; Joyner, Michael Joseph. / The effects of cross-linked hemoglobin on regional vascular conductance in dogs. In: Anesthesia and Analgesia. 1997 ; Vol. 85, No. 2. pp. 265-273.
@article{a657fb2efaf647d58ac8927931d63e44,
title = "The effects of cross-linked hemoglobin on regional vascular conductance in dogs",
abstract = "Hemoglobin (Hgb) solutions cause systemic vasoconstriction, which might limit their use as intraoperative blood substitutes. This constriction is thought to be caused by interaction between Hgb and nitric oxide (NO). To determine whether α-α cross-linked hemoglobin (XL-Hgb) interferes with NO- mediated vasodilation caused by acetylcholine (ACh) and sodium nitroprusside (NTP), we infused these compounds into the femoral, superior mesenteric, and circumflex coronary arteries of anesthetized dogs (n = 6) before and after partial exchange transfusion with XL-Hgb. Additional animals (n = 6) were studied after treatment with 5{\%} albumin. XL-Hgb administration increased mean arterial pressure (MAP) from 81 ± 5 to 112 ± 8 (P < 0.05). Albumin reduced MAP from 84 ± 4 mm Hg to 76 ± 4 mm Hg (P < 0.05). Vascular conductance after XL-Hgb decreased in the femoral artery, was not changed in the mesenteric bed, and increased modestly in the coronary artery (from 0.19 ± 0.03 to 0.26 ± 0.02 mL · mm Hg -1 · min -1, P < 0.05). After albumin, conductance was unchanged in the femoral artery and increased in the mesenteric artery. Conductance also increased in the coronary bed (from 0.25 ± 0.02 to 0.49 ± 0.03 mL · mm Hg -1 · min -1, P < 0.05). The vasodilator response to ACh in the femoral or mesenteric beds was either unaffected or augmented by either XL-Hgb or albumin. In the coronary bed, XL- Hgb blunted the dilator responses to ACh and NTP, while albumin augmented the coronary dilator responses to ACh. In five additional dogs, the NO synthase inhibitor N(G)-monomethyl L-arginine caused MAP to increase from 85 ± 4 to 90 ± 8 mm Hg and blunted the coronary dilator responses to ACh by approximately 25{\%}. Subsequent XL-Hgb administration caused a further increase in MAP to 112 ± 19 mm Hg (P < 0.05) and also further blunted ACh-mediated vasodilator responses in the coronary circulation. XL-Hgb has complex effects on the circulatory system, including a reduction in the vasodilator responses to ACh and NTP in canine coronary arteries in vivo. The potential impact of these events on patients with significant coexisting disease is unclear.",
author = "Dietz, {Niki M.} and Martin, {Crestin M.} and Beltran-del-Rio, {A. G.} and Joyner, {Michael Joseph}",
year = "1997",
month = "8",
doi = "10.1097/00000539-199708000-00005",
language = "English (US)",
volume = "85",
pages = "265--273",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The effects of cross-linked hemoglobin on regional vascular conductance in dogs

AU - Dietz, Niki M.

AU - Martin, Crestin M.

AU - Beltran-del-Rio, A. G.

AU - Joyner, Michael Joseph

PY - 1997/8

Y1 - 1997/8

N2 - Hemoglobin (Hgb) solutions cause systemic vasoconstriction, which might limit their use as intraoperative blood substitutes. This constriction is thought to be caused by interaction between Hgb and nitric oxide (NO). To determine whether α-α cross-linked hemoglobin (XL-Hgb) interferes with NO- mediated vasodilation caused by acetylcholine (ACh) and sodium nitroprusside (NTP), we infused these compounds into the femoral, superior mesenteric, and circumflex coronary arteries of anesthetized dogs (n = 6) before and after partial exchange transfusion with XL-Hgb. Additional animals (n = 6) were studied after treatment with 5% albumin. XL-Hgb administration increased mean arterial pressure (MAP) from 81 ± 5 to 112 ± 8 (P < 0.05). Albumin reduced MAP from 84 ± 4 mm Hg to 76 ± 4 mm Hg (P < 0.05). Vascular conductance after XL-Hgb decreased in the femoral artery, was not changed in the mesenteric bed, and increased modestly in the coronary artery (from 0.19 ± 0.03 to 0.26 ± 0.02 mL · mm Hg -1 · min -1, P < 0.05). After albumin, conductance was unchanged in the femoral artery and increased in the mesenteric artery. Conductance also increased in the coronary bed (from 0.25 ± 0.02 to 0.49 ± 0.03 mL · mm Hg -1 · min -1, P < 0.05). The vasodilator response to ACh in the femoral or mesenteric beds was either unaffected or augmented by either XL-Hgb or albumin. In the coronary bed, XL- Hgb blunted the dilator responses to ACh and NTP, while albumin augmented the coronary dilator responses to ACh. In five additional dogs, the NO synthase inhibitor N(G)-monomethyl L-arginine caused MAP to increase from 85 ± 4 to 90 ± 8 mm Hg and blunted the coronary dilator responses to ACh by approximately 25%. Subsequent XL-Hgb administration caused a further increase in MAP to 112 ± 19 mm Hg (P < 0.05) and also further blunted ACh-mediated vasodilator responses in the coronary circulation. XL-Hgb has complex effects on the circulatory system, including a reduction in the vasodilator responses to ACh and NTP in canine coronary arteries in vivo. The potential impact of these events on patients with significant coexisting disease is unclear.

AB - Hemoglobin (Hgb) solutions cause systemic vasoconstriction, which might limit their use as intraoperative blood substitutes. This constriction is thought to be caused by interaction between Hgb and nitric oxide (NO). To determine whether α-α cross-linked hemoglobin (XL-Hgb) interferes with NO- mediated vasodilation caused by acetylcholine (ACh) and sodium nitroprusside (NTP), we infused these compounds into the femoral, superior mesenteric, and circumflex coronary arteries of anesthetized dogs (n = 6) before and after partial exchange transfusion with XL-Hgb. Additional animals (n = 6) were studied after treatment with 5% albumin. XL-Hgb administration increased mean arterial pressure (MAP) from 81 ± 5 to 112 ± 8 (P < 0.05). Albumin reduced MAP from 84 ± 4 mm Hg to 76 ± 4 mm Hg (P < 0.05). Vascular conductance after XL-Hgb decreased in the femoral artery, was not changed in the mesenteric bed, and increased modestly in the coronary artery (from 0.19 ± 0.03 to 0.26 ± 0.02 mL · mm Hg -1 · min -1, P < 0.05). After albumin, conductance was unchanged in the femoral artery and increased in the mesenteric artery. Conductance also increased in the coronary bed (from 0.25 ± 0.02 to 0.49 ± 0.03 mL · mm Hg -1 · min -1, P < 0.05). The vasodilator response to ACh in the femoral or mesenteric beds was either unaffected or augmented by either XL-Hgb or albumin. In the coronary bed, XL- Hgb blunted the dilator responses to ACh and NTP, while albumin augmented the coronary dilator responses to ACh. In five additional dogs, the NO synthase inhibitor N(G)-monomethyl L-arginine caused MAP to increase from 85 ± 4 to 90 ± 8 mm Hg and blunted the coronary dilator responses to ACh by approximately 25%. Subsequent XL-Hgb administration caused a further increase in MAP to 112 ± 19 mm Hg (P < 0.05) and also further blunted ACh-mediated vasodilator responses in the coronary circulation. XL-Hgb has complex effects on the circulatory system, including a reduction in the vasodilator responses to ACh and NTP in canine coronary arteries in vivo. The potential impact of these events on patients with significant coexisting disease is unclear.

UR - http://www.scopus.com/inward/record.url?scp=0030876606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030876606&partnerID=8YFLogxK

U2 - 10.1097/00000539-199708000-00005

DO - 10.1097/00000539-199708000-00005

M3 - Article

VL - 85

SP - 265

EP - 273

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -